The role of empagliflozin-induced metabolic changes for cardiac function in patients with type 2 diabetes. A randomized cross-over magnetic resonance imaging study with insulin as comparator.

Roopameera ThirumathyamErik Arne RichterGerrit van HallJens Juul HolstMogens FengerJens P GøtzeUlrik DixenNiels VejlstrupSten MadsbadPer Lav MadsenNils Bruun Jørgensen

Published in: Cardiovascular diabetology (2024)

EudraCT 2017-002101-35, August 2017.

Keyphrases

magnetic resonance imaging
type diabetes
computed tomography
high glucose
diabetic rats
magnetic resonance
contrast enhanced
glycemic control
oxidative stress
endothelial cells
adipose tissue
insulin resistance